Hello BridgeBio, farewell Syros and Achilles
One step forward, two steps back for biotech.
Interest builds in a new synthetic lethality story
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
One step forward, two steps back for biotech.
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
